These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6782012)

  • 1. Serum concentration and functional efficiency of factor B alleles.
    Mauff G; Adam R; Wachauf B; Hitzeroth HW; Hiller C
    Immunobiology; 1980; 158(1-2):86-90. PubMed ID: 6782012
    [No Abstract]   [Full Text] [Related]  

  • 2. A hemolytically inactive gene product of factor B.
    Mauff G; Federmann G; Hauptmann G
    Immunobiology; 1980; 158(1-2):96-100. PubMed ID: 6782013
    [No Abstract]   [Full Text] [Related]  

  • 3. Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase.
    Schwaeble W; Lüttig B; Sokolowski T; Estaller C; Weiss EH; Meyer zum Büschenfelde KH; Whaley K; Dippold W
    Immunobiology; 1993 Jul; 188(3):221-32. PubMed ID: 8225386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in serum properdin factor B phenotype following human orthoptic liver transplantation.
    Hauptmann G; Tongio MM; Klein J; Mayer S; Cinqualbre J; Jeanblanc B; Kieny R
    Immunobiology; 1980; 158(1-2):76-81. PubMed ID: 7009411
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternative pathway of bovine complement: concentration of factor B, hemolytic activity and heritability.
    Tabel H; Menger M; Aston WP; Cochran M
    Vet Immunol Immunopathol; 1984 Mar; 5(4):389-98. PubMed ID: 6428035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a major serum DNA-binding protein as factor B of the alternative complement pathway.
    Gardner WD; Haselby JA; Hoch SO
    J Immunol; 1980 Jun; 124(6):2800-6. PubMed ID: 6989908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic study of properdin factor B in juvenile rheumatoid arthritis].
    Fioravanti A; Giordano N; Mariani A; Frati E; Fantini F; Malavasi F; Marcolongo R
    Boll Soc Ital Biol Sper; 1985 May; 61(5):763-8. PubMed ID: 3861185
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic polymorphism of properdin factor B (BF) in a Chinese population: existence of two rare variants.
    Luo ZJ; Du CS; Tokunaga K; Omoto K
    Jinrui Idengaku Zasshi; 1987 Mar; 32(1):33-8. PubMed ID: 3649419
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative differences between complement factor-B phenotypes.
    Mortensen JP; Lamm LU
    Immunology; 1981 Apr; 42(4):505-11. PubMed ID: 7016742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population genetic data on properdin factor B (Bf) in northern Germany.
    Püschel K; Schmidt M; Söder R; Brinkmann B
    Am J Phys Anthropol; 1979 Feb; 50(2):247-50. PubMed ID: 443359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factor B, factor D].
    Endo M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():73-6. PubMed ID: 20942005
    [No Abstract]   [Full Text] [Related]  

  • 13. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative pathway of complement by antiserum to factor B.
    Wilson MR; Arroyave CM; Tan EM
    J Lab Clin Med; 1979 Mar; 93(3):493-8. PubMed ID: 107255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies on properdin factor B (Bf) polymorphism in random samples from Brazil, Germany and Guinea-Bissau].
    Weissmann J; Taborda de Messias IJ; Pribilla O
    Anthropol Anz; 1983 Dec; 41(4):301-7. PubMed ID: 6559050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of properdin factor B(Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand.
    Greiner J; Weber FJ; Mauff G; Baur M
    Immunobiology; 1980; 158(1-2):134-8. PubMed ID: 6907169
    [No Abstract]   [Full Text] [Related]  

  • 17. Properdin factor B alleles in pre-eclampsia.
    Armstrong NP; Dyer PA; Klouda PT; Harris R
    Lancet; 1980 May; 1(8178):1145-6. PubMed ID: 6103487
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid determination of the human complement factor B phenotypes.
    Kramer J; Thiry E; Füst G
    Haematologia (Budap); 1989; 22(2):97-100. PubMed ID: 2744642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of subtypes of the Bf system: distribution in a random sample from the population of Berlin (GDR)].
    Geserick G; Patzelt D; Schröder H
    Biomed Biochim Acta; 1983; 42(5):581-5. PubMed ID: 6557813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical characterization of human factor B of the alternate pathway of complement activation.
    Curman B; Sandberg-Trägårdh L; Peterson PA
    Biochemistry; 1977 Nov; 16(24):5368-75. PubMed ID: 411505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.